The Dynamic Impact of CSR on the Relationship Between Financial Performance and Firm Value
Sage Open · 2026-10 · 16 (4)
DOI: 10.1177/21582440261505071 ↗Kurz gefasst
Fachartikel in der Zeitschrift Sage Open, online erschienen am 04.11.2026. Verfasst von Jau-Rong Chen und 4 weiteren Autor:innen. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Using data from 404 businesses listed on the Indonesia Stock Exchange from 2012 to 2018, this study employs a panel smooth transition regression (PSTR) model to explore the nonlinear relationship between sales and net income, key financial performance indicators, and corporate performance (Tobin’s Q) within the context of a corporate social responsibility (CSR) threshold. The empirical results confirm a significant CSR threshold effect, indicating that the relationship between financial performance and firm value is nonlinear. When CSR exceeds the threshold value, sales positively affect Tobin’s Q, whereas sales exert a negative effect below the threshold. Net income remains negatively associated with Tobin’s Q in both CSR regimes; however, the magnitude of this negative effect becomes substantially smaller once the CSR threshold is exceeded.
Zitieren
APA
Chen, J., Yang, T., Chang, C., Permatasari, R., & Itan, I. (2026). The Dynamic Impact of CSR on the Relationship Between Financial Performance and Firm Value. Sage Open, 16(4). https://doi.org/10.1177/21582440261505071
Vancouver
Chen J, Yang T, Chang C, Permatasari R, Itan I. The Dynamic Impact of CSR on the Relationship Between Financial Performance and Firm Value. Sage Open. 2026;16(4). doi:10.1177/21582440261505071
BibTeX
@article{Chen2026,
author = {Chen, Jau-Rong and Yang, Tzu-Yi and Chang, Chia-Jui and Permatasari, Rika and Itan, Iskandar},
title = {The Dynamic Impact of CSR on the Relationship Between Financial Performance and Firm Value},
journal = {Sage Open},
year = {2026},
volume = {16},
number = {4},
doi = {10.1177/21582440261505071}
}
EUVIMED